Healthcare >> CEO Interviews >> October 12, 2001
LISA N. DRAKEMAN is the Chief Executive Officer of Genemab. Dr. Drakeman
has been named 'Advocate of the Year' by the national Biotechnology
Industry Organization. She has over ten year's experience working in the
biotechnology industry, including establishing corporate partnerships
with major pharmaceutical companies, managing clinical trials of
monoclonal antibody-based products and developing government programs
for financing biotechnology research. She previously served as a member
of the faculty and administration at Princeton University. She is a
Trustee and Chief Financial Officer of the Prosperity New Jersey public-
private partnership. Dr. Drakeman previously served as Senior Vice
President, Head of Business Development for Medarex. She received a BA
degree, from Mount Holyoke College, MA degree from Rutgers University,
and an MA and Ph.D., from Princeton University. Profile
Dr. Drakeman: Genmab is a European biotechnology company developing a
portfolio of antibody products. We use the most advanced human
